Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
07/1998
07/02/1998WO1998027931A2 Salts of acetaminophen
07/02/1998DE19757627A1 Azulenderivate, Verfahren zu deren Herstellung und pharmazeutische Zusammensetzung, die diese Verbindungen enthält Azulene derivatives, processes for their preparation and pharmaceutical composition containing these compounds
07/02/1998CA2276090A1 Recombinant n-smases and nucleic acids encoding same
07/02/1998CA2275271A1 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
07/02/1998CA2275174A1 Salts of acetaminophen
07/02/1998CA2275163A1 Spiro-substituted azacyclic-substituted piperazino derivatives as neurokinin antagonists
07/02/1998CA2274769A1 New treatment for joint inflammation
07/02/1998CA2274117A1 Novel compounds with analgesic effect
07/01/1998EP0850909A1 Stilbene compounds with adamantyl group, compositions containing the same and uses
07/01/1998EP0850240A1 Methods for in vivo reduction of nitric oxide levels and compositions useful therefor
07/01/1998EP0850236A1 Piperazino derivatives as neurokinin antagonists
07/01/1998EP0850232A1 Benzothiazolone derivatives
07/01/1998EP0850228A1 Pyrimidine carboxamides and related compounds and methods for treating inflammatory conditions
07/01/1998EP0850215A1 N-(aroyl)glycine hydroxamic acid derivatives and related compounds
07/01/1998EP0850068A1 Lipid extract having anti-inflammatory activity
07/01/1998EP0721352A4 Novel receptor-type phosphotyrosine phosphatase-sigma
07/01/1998EP0654041B1 Peptidyl 4-amino-2,2-difluoro-3-oxo-1,6-hexanedioic acid derivatives as antiinflammatory agents
07/01/1998CN1186518A Human vascular endothelial growth factor 2
07/01/1998CN1186501A Human chemokine beta-8, chemokine beta-1 and macrophage inflammatory protein-4
07/01/1998CN1186495A Methods for in vivo reduction of nitric oxide levels and compositions useful therefor
07/01/1998CN1186492A Imidazo £1, 2-alpha| pyridine derivatives
07/01/1998CN1186431A Compositions and methods using nitroxides in combination with biocompatible macromolecules
07/01/1998CN1038939C Preparation of peptide compounds
07/01/1998CN1038932C Stereoselective preparation of substitued piperidines
06/1998
06/30/1998US5773620 Quaternary ammonium salts of aromatic amine compounds, their preparation and pharmaceutical compositions in which they are present
06/30/1998US5773570 Vaccine compositions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis
06/30/1998US5773470 Treating rheumatic diseases, autoimmune diseases and rejection reactions due to organ transplanting
06/30/1998US5773467 Inhibitors of phosphodiesterases and tumor necrosis factor
06/30/1998US5773452 Alzheimer's disease; cognition activators
06/30/1998US5773450 Fluoroalkoxybenzylamino derivatives of nitrogen containing heterocycles
06/30/1998US5773440 Antiinflammatory agent
06/30/1998US5773438 Synthetic matrix metalloprotease inhibitors and use thereof
06/30/1998US5773430 Reduces tissue destruction during inflammation resulting from the activity of human leukocyte elastase
06/30/1998US5773231 Treatment for atherosclerosis and other cardiovascular and inflammatory diseases
06/30/1998US5773209 Prevention of formation of oxidized polyunsaturated fatty acid, suppression of gene expression through redox sensitive pathways
06/25/1998WO1998027108A2 New amide compounds and their use as nitric oxide synthase inhibitors
06/25/1998WO1998027098A1 SUBSTITUTED NITROGEN CONTAINING HETEROCYCLES AS INHIBITORS OF p38 PROTEIN KINASE
06/25/1998WO1998027086A1 Novel heterocyclic substituted pyrrolidine amide derivatives
06/25/1998WO1998026794A1 Pharmaceutical composition containing an inhibitor of immunoglobulin-receptor interaction
06/25/1998WO1998026788A1 Medical composition and use thereof for the manufacture of a topical barrier formulation, a uv-radiation absorbing formulation, or an antiviral, antifungal, or antiinflammatory formulation
06/25/1998WO1998019649A3 Methods and compositions for inhibition of angiogenesis
06/25/1998WO1998017268A3 Method of alleviating pain by means of combining tramadol with an nmda antagonist
06/25/1998WO1998011887A3 Viral inhibition by long-chain alcohols, alkanes, fatty acids and amides
06/25/1998CA2275213A1 Pharmaceutical composition containing an inhibitor of immunoglobulin-receptor interaction
06/24/1998EP0849256A1 Amide compounds and use of the same
06/24/1998EP0848706A1 Substituted benzene-fused hetero- and carbocyclics as neurokinin antagonists
06/24/1998EP0848703A1 Derivatives of benzosulphonamides as inhibitors of the enzyme cyclo-oxygenase ii
06/24/1998CN1185742A Protein kinase c inhibitors
06/24/1998CN1185737A Isothiazolones
06/24/1998CN1185325A Ointment of drawing out pus for curing bone inflammation and preparation technology thereof
06/24/1998CN1185319A Tumor-blood-vessel growth inhibitor and medicinal composition
06/23/1998US5770772 4-formylamino-2,3,5-trimethyl-1-(2-methyl-2-propenyloxy) -benzene; arteriosclerosis, brain and cardiovascular disorders
06/23/1998US5770735 Neurokinin receptor antagonists
06/23/1998US5770624 Inhibitors of tumor necrosis factor alpha and matrix degrading metalloproteinease activity
06/23/1998US5770602 Quinoline or quinazoline derivatives, their production and use
06/23/1998US5770594 Naphthyl-benzoxazepines or -benzothiazepines as squalene synthetase inhibitors
06/23/1998US5770586 Quaternary nitrogen-containing phosphonate compounds, pharmaceutical compositions, and methods of treating abnormal calcium and phosphate metabolism amd methods of treating and preventing dental calculus and plaque
06/23/1998US5770574 Long-chain alkylamides of amino acids and peptides with anti-proliferative and anti-inflammatory properties
06/23/1998US5770573 CS-1 peptidomimetics, compositions and methods of using the same
06/23/1998US5770568 Variants of bovine pancreatic trypsin inhibitor produced by recombinant DNA technology, process expression vector and recombinant host therefor and pharmaceutical use thereof
06/23/1998US5770401 Such as cutaneous, ocular, nasal and bronchial allergic disease; interleukins and tumor necrosis factor receptors; competitive binding
06/23/1998US5770197 Methods for regulating the immune response using B7 binding molecules and IL4-binding molecules
06/23/1998US5770196 Modified antibody variable domains and therapeutic uses thereof
06/23/1998CA2176506C Substituted oxindoles
06/23/1998CA2119636C Low ph aqueous cosmetic gel containing non-ionic polyacrylamide derivatives
06/23/1998CA2033531C Azaoxindole derivatives
06/23/1998CA2008739C Compositions and method for the treatment of disease
06/20/1998CA2225273A1 Vitronectin receptor antagonists, their preparation and their use
06/20/1998CA2225267A1 Vitronectin receptor antagonists, their preparation and their use
06/18/1998WO1998026069A1 Methods and compositions for identifying morphogen analogs
06/18/1998WO1998026068A1 Human apoptosis-related calcium-binding protein
06/18/1998WO1998026047A1 Methods and compositions for identifying morphogen analogs
06/18/1998WO1998025971A1 Monovalent antibody fragments
06/18/1998WO1998025951A1 Inhibitors of peptide binding to mhc class ii proteins
06/18/1998WO1998025920A1 3-pyridyl enantiomers and their use as analgesics
06/18/1998WO1998025919A1 Benzothiophenecarboxamide derivatives and pgd2 antagonists comprising them
06/18/1998WO1998025875A1 ARYL OR HETEROARYL SUBSTITUTED 3,4-DIHYDROANTHRACENE AND ARYL OR HETEROARYL SUBSTITUTED BENZO[1,2-g]-CHROM-3-ENE, BENZO[1,2-g]-THIOCHROM-3-ENE AND BENZO[1,2-g]-1,2-DIHYDROQUINOLINE DERIVATIVES HAVING RETINOID ANTAGONIST OR RETINOID INVERSE AGONIST TYPE BIOLOGICAL ACTIVITY
06/18/1998WO1998025627A1 17α-DIHYDROEQUILENIN FOR USE AS A MEDICAL ANTIOXIDANT
06/18/1998WO1998025626A1 Use of equilenin as an antioxidant
06/18/1998WO1998025625A1 USE OF 17β-DIHYDROEQUILENIN AS AN ANTIOXIDANT
06/18/1998WO1998025619A1 Novel compounds
06/18/1998WO1998025609A1 PYRROLES AS sPLA2 INHIBITORS
06/18/1998WO1998025595A2 Aqueous drink composition comprising ibuprofen
06/18/1998WO1998025593A2 2-CYCLOPENTEN-1-ONE AND ITS DERIVATIVES AS INHIBITORS OF THE NF-kB FACTOR
06/18/1998WO1998025584A2 Cosmetic preparation with a peptide addition
06/18/1998WO1998025469A1 The use of cd4-binding small molecules to inhibit immune responses
06/18/1998WO1998005361A3 Long-acting drugs and pharmaceutical compositions comprising them
06/18/1998DE19653736A1 Kosmetisches Präparat mit Peptidzusatz A cosmetic preparation with additional peptide
06/18/1998CA2274838A1 Aryl or heteroaryl substituted 3,4-dihydroanthracene and aryl or heteroaryl substituted benzo[1,2-g]-chrom-3-ene, benzo[1,2-g]-thiochrom-3-ene and benzo[1,2-g]-1,2-dihydroquinoline derivatives having retinoid antagonist or retinoid inverse agonist type biological activity
06/18/1998CA2274739A1 Human apoptosis-related calcium-binding protein
06/18/1998CA2274655A1 Novel compounds
06/18/1998CA2274604A1 The use of cd4-binding small molecules to inhibit immune responses
06/18/1998CA2274571A1 Pyrroles as spla2 inhibitors
06/18/1998CA2272089A1 17.alpha.-dihydroequilenin for use as a medical antioxidant
06/18/1998CA2272087A1 Use of equilenin as an antioxidant
06/18/1998CA2272074A1 Use of 17.beta.-dihydroequilenin as an antioxidant
06/18/1998CA2271919A1 Cosmetic preparation with a peptide addition
06/17/1998EP0848063A2 Nucleic acid constructs containing hybrid promotors for use in gene therapy
06/17/1998EP0848061A2 Self-enhancing, pharmacologically controllable expression systems
06/17/1998EP0848060A2 Novel human 11CB splice variant
1 ... 1114 1115 1116 1117 1118 1119 1120 1121 1122 1123 1124 1125 1126 1127 1128 1129 1130 1131 1132 1133 1134 ... 1272